CNC vs MDXG: fair value comparison
Centene Corporation and MiMedx Group, Inc. · Updated 2026-09-12
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, CNC currently sits closer to the top of our discount ranking. MDXG carries the stronger quality grade.
| CNC | MDXG | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $66.42 | $4.52 |
| 12-month range | $33.95–$65.23 | $3.58–$7.52 |
| Sector rank | #98 of 113 Healthcare | #100 of 113 Healthcare |
| Quality grade | F | D |
| Leverage | Moderate | Low |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | Undervalued | Overvalued |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: CNC fair value analysis · MDXG fair value analysis